Clinical characteristics and outcomes among Brazilian patients with severe acute respiratory syndrome coronavirus 2 infection
an observational retrospective study
Keywords:
Severe acute respiratory syndrome coronavirus 2 [supplementary concept], COVID-19 [supplementary concept], Coronavirus infections, Mandatory reporting, Public reporting of healthcare dataAbstract
BACKGROUND: Since February 2020, data on the clinical features of patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and their clinical evolution have been gathered and intensively discussed, especially in countries with dramatic dissemination of this disease. OBJECTIVE: To assess the clinical features of Brazilian patients with SARS-CoV-2 and analyze its local epi- demiological features. DESIGN AND SETTING: Observational retrospective study conducted using data from an official electron- ic platform for recording confirmed SARS-CoV-2 cases. METHODS: We extracted data from patients based in the state of Pernambuco who were registered on the platform of the Center for Strategic Health Surveillance Information, between February 26 and May 25, 2020. Clinical signs/symptoms, case evolution over time, distribution of confirmed, recovered and fatal cases and relationship between age group and gender were assessed. RESULTS: We included 28,854 patients who were positive for SARS-CoV-2 (56.13% females), of median age 44.18 years. SARS-CoV-2 infection was most frequent among adults aged 30-39 years. Among cases that progressed to death, the most frequent age range was 70-79 years. Overall, the mortality rate in the cohort was 8.06%; recovery rate, 30.7%; and hospital admission rate (up to the end of follow-up), 17.3%. The average length of time between symptom onset and death was 10.3 days. The most commonly re- ported symptoms were coughing (42.39%), fever (38.03%) and dyspnea/respiratory distress with oxygen saturation < 95% (30.98%). CONCLUSION: Coughing, fever and dyspnea/respiratory distress with oxygen saturation < 95% were the commonest symptoms. The case-fatality rate was 8.06% and the hospitalization rate, 17.3%.
Downloads
References
Johns Hopkins, Coronavirus Resource Center. COVID-19 Dashboard of the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from: https://coronavirus.jhu.edu/map.html. Accessed in 2020 (Jul 3).
Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. PMID: 32109013; doi: 10.1056/NEJMoa2002032.
Borges do Nascimento IJ, Cacic N, Abdulazeem HM, et al. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. J Clin Med. 2020;9(4):941. PMID: 32235486; doi: 10.3390/jcm9040941.
Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020;130(7):1787. PMID: 32237238; doi: 10.1002/lary.28692.
Gilani S, Roditi R, Naraghi M. COVID-19 and anosmia in Tehran, Iran. Med Hypotheses. 2020;141:109757. PMID: 32344276; doi: 10.1016/j. mehy.2020.109757.
Joob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol. 2020;82(5):e177. PMID: 32213305; doi: 10.1016/j.jaad.2020.03.036.
Sociedade Brasileira de Dermatologia. Manifestações na pele devido à COVID-19 causadas pelo vírus SARS-CoV-2: fatos e fotos até 17 de abril de 2020. Available from: https://www.sbd.org.br/mm/cms/2020/04/21/artigo-manifestacoes-pele-dr-paulo-criado-revisado-final.pdf. Accessed in 2020 (Jul 3).
Muniz BC, Milito MA, Marchiori E. COVID-19 − Computed tomography findings in two patients in Petrópolis, Rio de Janeiro, Brazil. Rev Soc Bras Med Trop. 2020;53:e20200147. PMID: 32321099; doi: 10.1590/0037-8682-0147-2020.
Chate RC, Fonseca EKUN, Passos RBD, et al. Presentation of pulmonary infection on CT in COVID-19: initial experience in Brazil. J Bras Pneumol. 2020;46(2):e20200121. PMID: 32294718; doi: 10.36416/1806-3756/e20200121.
Bastos LS, Niquini RP, Lana RM, et al. COVID-19 e hospitalizações por SRAG no Brasil: uma comparação até a 12a semana epidemiológica de 2020 [COVID-19 and hospitalizations for SARI in Brazil: a comparison up to the 12th epidemiological week of 2020]. Cad Saude Publica. 2020;34(4):e00070120. PMID: 32321075; doi: 10.1590/0102-311X00070120.
Ministério da Saúde. Brasil. Painel Coronavirus. Available from: https://covid.saude.gov.br. Accessed in 2020 (Jul 3).
Governo do Estado do Pernambuco. Geografia de Pernambuco. Available from: http://www.pe.gov.br/conheca/geografia/. Accessed in 2020 (Jul 3).
Ministério da Economia. Brasil. Radar IDHM: evolução do ISHM e de seus índices componentes no período de 2012 a 2017. Brasília: IPEA, PNUD, FJP; 2019. Available from: http://atlasbrasil.org.br/2013/data/rawData/Radar%20IDHM%20PNADC_2019_Book.pdf. Accessed in 2020 (Jul 3).
Secretaria do Planejamento e Gestão, Secretaria de Saúde, Agência Estadual de Tecnologia da Informação. Painel de casos de doença pelo coronavirus 2019 (COVID-19) em Pernambuco, no Brasil e no Mundo. Available from: https://dados.seplag.pe.gov.br/apps/corona. html. Accessed in 2020 (Jul 3).
Menezes PL, Garner DM, Valenti VE. Brazil is projected to be the next global COVID-19 pandemic epicenter. medRxiv preprint. doi: 10.1101/2020.04.28.20083675.
Darlington S, Crespo G, John T. Latin America is now the “epicenter of the outbreak,” says health official. CNN. Available from: https://edition.cnn.com/2020/05/26/americas/latin-america-coronavirus-toll-intl/index.html. Accessed in 2020 (Jul 3).
Lindoso JA, Lindoso AA. Neglected tropical diseases in Brazil. Rev Inst Med Trop Sao Paulo. 2009;51(5):247-53. PMID: 19893976; doi: 10.1590/s0036-46652009000500003.
Barros MB. Social inequality in health: revisiting moments and trends in 50 years of publication of RSP. Rev Saude Publica. 2017;51(0):17. PMID: 28355334; doi: 10.1590/S1518-8787.2017051000156.
TelessaúdeRS. Universidade Federal do Rio Grande do Sul. Quais são os diagnósticos diferenciais da COVID-19? 2020. Available from: https://www.ufrgs.br/telessauders/perguntas/quais-sao-os-diagnosticos-diferenciais-da-covid-19/. Accessed in 2020 (Jul 3).
Ministério da Saúde. Secretaria de Vigilância em Saúde. Sistema de Informação sobre Mortalidade – SIM. Available from: http://tabnet.datasus. gov.br/cgi/tabcgi.exe?sim/cnv/obt10uf.def. Accessed in 2020 (Jul 3).
Lippi G, Mattiuzzi C, Sanchis-Gomar F, Henry BM. Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China. [published online ahead of print, 2020 Apr 10]. J Med Virol. 2020;10.1002/jmv.25860. PMID: 32275075; doi: 10.1002/jmv.25860.
Li LQ, Huang T, Wang YG, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577-83. PMID: 32162702; doi: 10.1002/jmv.25757.
Bernardi S, Toffoli B, Tonon F, et al. Sex Differences in Proatherogenic Cytokine Levels. Int J Mol Sci. 2020;21(11):3861. PMID: 32485823; doi: 10.3390/ijms21113861.
Ter Horst R, Jaeger M, Smeekens SP, et al. Host and Environmental Factors Influencing Individual Human Cytokine Responses. Cell. 2016;167(4):1111-24. PMID: 27814508; doi: 10.1016/j.cell.2016.10.018.
Arnold AP. The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm Behav. 2009;55(5):570-8. PMID: 19446073; doi: 10.1016/j.yhbeh.2009.03.011.
Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J Biol Regul Homeost Agents. 2020;34(2):10.23812. Available from: https://pesquisa.bvsalud.org/controlecancer/resource/pt/mdl-32253888. Accessed in 2020 (Jul 3).
Qureshi S, Medzhitov R. Toll-like receptors and their role in experimental models of microbial infection. Genes Immun. 2003;4(2):87-94. PMID: 12618855; doi: 10.1038/sj.gene.6363937.
De Oliveira MM, Daher DV, Da Silva JL, Andrade SS. Men’s health in question: seeking assistance in primary health care. Cienc Saude Colet. 2015;20(1):273-8. PMID: 25650621; doi: 10.1590/1413-81232014201.21732013.
Gomes R. Sexualidade Masculina, Gênero e Saúde. Rio de Janeiro: Fiocruz; 2008.
Gomes R, Nascimento EF, Araújo FC. Por que os homens buscam menos os serviços de saúde do que as mulheres? As explicações de homens com baixa escolaridade e homens com ensino superior [Why do men use health services less than women? Explanations by men with low versus higher education]. Cad Saude Publica 2007;23(3):565-74. PMID: 17334571; doi: 10.1590/s0102-311x2007000300015.
